Pharmacology and Toxicology Department Highlights: March 2021
Feb. 25, 2021
(March 1, 2021)
Publications
Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures. BioRxiv. 2021.02.13.431008.
- Shen, Z.
- Ratia, K.
- Cooper, L.
- Kong, D.
- Lee, H
- Kwon, Y.
- Li, Y
- Alqarni, S.
- Huang, F.
- Dubrovskyi, O.
- Rong, L.
- Gregory Thatcher, PhD
- Xiong, R.
Extending the Calpain–Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma ACS Pharmacol. Transl. Sci. 2021, 4, 1, 372–385.
- Knopp, R.
- Jastaniah, A.
- Dubrovskyi, O.
- Gaisina, I.
- Tai, L.
- Gregory Thatcher, PhD
Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry Plos Pathogens. 2021 Feb 4;17(2):e1009312.
- Schafer, A.
- Xiong, R.
- Cooper, L.
- Nowar, R.
- Lee, H.
- Li, Y.
- Ramirez, B.
- Peet, N.
- Caffrey, M.
- Gregory Thatcher, PhD
- Saphire, E.
- Cheng, H.
- Rong, L.
Comparison of L-Carnitine and L-Carnitine HCL Salt for Targeted Lung Treatment of Pulmonary Hypertension (PH) as Inhalation Aerosols: Design, Comprehensive Characterization, In Vitro 2D/3D Human Lung Cell Cultures, and In Vivo MCT-Rat Model of PH. Pulm Pharmacol Ther. 2021 Feb 5:101998.
- Acosta, M.
- Muralidhran, P.
- Abrahamson, M.
- Grijalva, C.
- Carver, M.
- Tang, H.
- Klinger, C.
- Fineman, J.
- Black, S.
- Heidi Mansour, PhD, RPh